James David Jentsch,

Dr. James David Jentsch,

Department of Psychology, Binghamton University, Binghamton, NY, USA
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2014 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JJJames David Jentsch,
James David Jentsch,
JAJames R. Ashenhurst
James R. Ashenhurst
MCM. Catalina Cervantes
M. Catalina Cervantes
SGStephanie M. Groman
Stephanie M. Groman
AJAlexander S. James
Alexander S. James
ZPZachary T. Pennington
Zachary T. Pennington

1 May 2009 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
SGStephanie M. Groman
Stephanie M. Groman
AJAlex S. James
Alex S. James
JJJames David Jentsch,
James David Jentsch,

14 February 2007 in Neuropsychopharmacology
Verified
Journal Article
Closed access
BLBuyean Lee
Buyean Lee
SGStephanie Groman
Stephanie Groman
ELEdythe D London
Edythe D London
JJJames David Jentsch,
James David Jentsch,

22 October 2014 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
SGStephanie M. Groman
Stephanie M. Groman
AJAlex S. James
Alex S. James
ESEmanuele Seu
Emanuele Seu
STSteven Tran
Steven Tran
TCTaylor A. Clark
Taylor A. Clark
JJJames David Jentsch,
James David Jentsch,
For >30 years, positron emission tomography (PET) has proven to be a powerful approach for measuring aspects of dopaminergic transmission in the living human brain; this technique has revealed important relationships between dopamine D2-like receptors and dimensions of normal behavior, such as human impulsivity, and psychopathology, particularly behavioral addictions. Nevertheless, PET is an indirect estimate that lacks cellular and functional resolution and, in some cases, is not entirely pharmacologically specific. To identify the relationships between PET estimates of D2-like receptor availability and directin vitromeasures of receptor number, affinity, and function, we conducted neuroimaging and behavioral and molecular pharmacological assessments in a group of adult male vervet monkeys. Data gathered from these studies indicate that variation in D2-like receptor PET measurements is related to reversal-learning performance and sensitivity to positive feedback and is associated within vitroestimates of the density of functional dopamine D2-like receptors. Furthermore, we report that a simple behavioral measure, eyeblink rate, reveals novel and crucial links between neuroimaging assessments andin vitromeasures of dopamine D2receptors.

1 January 2014 in Neuropharmacology
Verified
Journal Article
Closed access
JJJames David Jentsch,
James David Jentsch,
ZPZachary T. Pennington
Zachary T. Pennington

7 July 2008 in Psychopharmacology
Verified
Journal Article
Open access
PDF file
ESEmanuele Seu
Emanuele Seu
ALAndrew Lang
Andrew Lang
RRRonald J. Rivera
Ronald J. Rivera
JJJames David Jentsch,
James David Jentsch,
Poor cognitive control, including reversal learning deficits, has been reported in children with attention deficit hyperactivity disorder, in stimulant-dependent humans, and in animal models of these disorders; these conditions have each been associated with abnormal catecholaminergic function within the prefrontal cortex. In the current studies, we sought to explore how elevations in extracellular catecholamine levels, produced by pharmacological inhibition of catecholamine reuptake proteins, affect behavioral flexibility in rats and monkeys. Adult male Long–Evans rats and vervet monkeys were trained, respectively, on a four-position discrimination task or a three-choice visual discrimination task. Following systemic administration of pharmacological inhibitors of the dopamine and/or norepinephrine membrane transporters, rats and monkeys were exposed to retention or reversal of acquired discriminations. In accordance with our a priori hypothesis, we found that drugs that inhibit norepinephrine transporters, such as methylphenidate, atomoxetine, and desipramine, improved reversal performance in rats and monkeys; this was mainly due to a decrease in the number of perseverative errors. Interestingly, the mixed dopamine and norepinephrine transporters inhibitor methylphenidate, if anything, impaired performance during retention in both rats and monkeys, while administration of the selective dopamine transporter inhibitor GBR-12909 increased premature responses but did not alter reversal learning performance. Our results suggest that pharmacological inhibition of the membrane norepinephrine, but not membrane dopamine, transporter is associated with enhanced behavioral flexibility. These data, combined with earlier reports, may indicate that enhanced extracellular catecholamine levels in cortical regions, secondary to norepinephrine reuptake inhibition, improves multiple aspects of inhibitory control over responding in rats and monkeys.